Disturbances in Heart Rhythm
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Conduction System of the Heart
Depolarizing Blockers: Mechanism of Action
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 27, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
David T Zhang1, Anthony V Delicce1, Roger Fan1
1Division of Cardiology, Department of Medicine, Stony Brook Medicine, Stony Brook, New York.
No abstract available in PubMed .